#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Stress cardiomyopathy Tuberous sclerosis complex Essential thrombocythaemia Idiopathic intracranial hypertension Retinopathy of prematurity Soft tissue sarcoma Heritable pulmonary arterial hypertension Neurofibromatosis Hidradenitis Immune-mediated renal disorder Transient ischaemic attack Hypoxic-ischaemic encephalopathy Hyperadrenocorticism HER2 mutant non-small cell lung cancer Congenital nephrogenic diabetes insipidus More trials…

    Learn about Rare Diseases

    Factor VIII deficiency – Diagnostics Inclusion body myositis – Diagnostics Alagille syndrome – Treatment Pleural mesothelioma malignant – Basic Information Haemophilia B with anti factor IX – Diagnostics Atypical teratoid/rhabdoid tumour of CNS – Treatment Hypereosinophilic syndrome – Treatment Richter’s syndrome – Basic Information Rett syndrome – Basic Information Isodicentric chromosome 15 syndrome – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Cetirizine Propranolol Hydrochloride Povetacicept Tiemonium Methylsulphate Etrasimod Arginine Munc-Cd34 Trimetazidine Dihydrochloride Carbidopa Elraglusib Disodium Folinate Piritramide Nedosiran ZINC GLUCONATE Stro-002 Paltusotine Gr0015 Sulfonamides, Urea Derivatives Autologous Chondrocytes Gebasaxturev Gskvx000000017033 More therapies…

    Learn about Your Condition

    Gingival bleeding Thyroid mass Parkinson's disease Vertigo Lung adenocarcinoma stage IV Peritoneal cancer index Procedural haemorrhage Pancreatic carcinoma Exudative retinopathy Coagulopathy Phenylketonuria Premature rupture of membranes Deep vein thrombosis Optic atrophy Ocular myasthenia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study of olverembatinib with chemotherapy versus standard therapy in adults with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Philadelphia positive acute lymphocytic leukaemia
    • Acute lymphocytic leukaemia
    Investigated Drugs:
    • OLVEREMBATINIB
    • Imatinib Mesilate
    • Ponatinib
    Bulgaria Czechia France Germany Greece Hungary +3

  • Study of belumosudil in children aged 1 to 18 years with moderate to severe chronic graft versus host disease requiring systemic treatment

    Recruiting

    1 1 1
    Investigated Diseases:
    • Chronic graft versus host disease
    Investigated Drugs:
    • Belumosudil Mesilate
    Belgium France Germany Italy The Netherlands Spain

  • Study of dostarlimab treatment before surgery in patients with stage II-III endometrial cancer with specific genetic markers

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Endometrial cancer stage II
    • Endometrial cancer stage III
    • Endometrial cancer
    Investigated Drugs:
    • Dostarlimab
    Spain

  • Study of Tarlatamab and Temozolomide combination treatment in adolescents and adults with high grade brain tumors

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Brain neoplasm
    Investigated Drugs:
    • Tarlatamab
    • Temozolomide
    France

  • Study of Faricimab treatment to improve vision in patients with diabetic macular edema using adaptive optics imaging

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Faricimab
    Germany

  • Study of loncastuximab tesirine and epcoritamab combination treatment for patients with relapsed or refractory diffuse large B-cell lymphoma

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Loncastuximab Tesirine
    • Epcoritamab
    Germany
Previous Page
1 … 132 133 134 135 136 … 1,648
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!